Article ; Online: Adapting Deep Learning QSPR Models to Specific Drug Discovery Projects.
2024 Volume 21, Issue 4, Page(s) 1817–1826
Abstract: ... projects typically focus on confined parts of the chemical space (e.g., chemical series ... of training set size was analyzed, WI fine-tuning was found to be successful even in low-data scenarios (e.g ...
| Abstract | Medicinal chemistry and drug design efforts can be assisted by machine learning (ML) models that relate the molecular structure to compound properties. Such quantitative structure-property relationship models are generally trained on large data sets that include diverse chemical series (global models). In the pharmaceutical industry, these ML global models are available across discovery projects as an "out-of-the-box" solution to assist in drug design, synthesis prioritization, and experiment selection. However, drug discovery projects typically focus on confined parts of the chemical space (e.g., chemical series), where global models might not be applicable. Local ML models are sometimes generated to focus on specific projects or series. Herein, ML-based global models, local models, and hybrid global-local strategies were benchmarked. Analyses were done for more than 300 drug discovery projects at Novartis and ten absorption, distribution, metabolism, and excretion (ADME) assays. In this work, hybrid global-local strategies based on transfer learning approaches were proposed to leverage both historical ADME data (global) and project-specific data (local) to adapt model predictions. Fine-tuning a pretrained global ML model (used for weights' initialization, WI) was the top-performing method. Average improvements of mean absolute errors across all assays were 16% and 27% compared with global and local models, respectively. Interestingly, when the effect of training set size was analyzed, WI fine-tuning was found to be successful even in low-data scenarios (e.g., ∼10 molecules per project). Taken together, this work highlights the potential of domain adaptation in the field of molecular property predictions to refine existing pretrained models on a new compound data distribution. |
|---|---|
| MeSH term(s) | Deep Learning ; Drug Discovery/methods ; Drug Design ; Machine Learning ; Quantitative Structure-Activity Relationship |
| Language | English |
| Publishing date | 2024-02-19 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2138405-8 |
| ISSN | 1543-8392 ; 1543-8384 |
| ISSN (online) | 1543-8392 |
| ISSN | 1543-8384 |
| DOI | 10.1021/acs.molpharmaceut.3c01124 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6250: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.